A new TB drug with a novel mechanism of action – delamanid – is now available for treatment of adults with multidrug-resistant tuberculosis (MDR-TB), a form of tuberculosis resistant to …
Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2024. Contact us.